Abstract
Aim of review: This systematic review (PROSPERO CRD42018109084) aims to identify and analyse qualitative research studies exploring the barriers and facilitators to reducing anticholinergic burden.
Methods: Medline (OVID), EMBASE (OVID), CINAHL (EMBSCO) and PsycINFO (OVID) were searched using comprehensive search terms. Peer reviewed studies published in English presenting qualitative research in relation to the barriers and facilitators of deprescribing anticholinergic medications, involving patients, carers or health professionals were eligible. Normalization Process
Theory was used to explore and explain the data.
Results: Of 1,764 identified studies, two were eligible and both involved healthcare professionals (23 general practitioners, 13 specialist clinicians and 12 pharmacists). No studies were identified that involved patients or carers. Barriers to collaborative working often resulted in poor motivation to reduce anticholinergic use. Low confidence, system resources and organisation of care also hindered anticholinergic burden reduction. Good communication and relationships with patients, carers and other healthcare professionals were reported as important for successful anticholinergic burden reduction. Having a named person for prescribing decisions, and clear role boundaries, were also important facilitators.
Conclusions: This review identified important barriers and facilitators to anticholinergic burden reduction from healthcare provider perspectives which can inform implementation of such deprescribing interventions. Studies exploring patient and carer perspectives are presently absent but are required to ensure person-centeredness and feasibility of future interventions.
| Original language | English |
|---|---|
| Pages (from-to) | 1451-1460 |
| Number of pages | 10 |
| Journal | International Journal of Clinical Pharmacy |
| Volume | 43 |
| Early online date | 25 Jun 2021 |
| DOIs | |
| Publication status | Published - Dec 2021 |
Bibliographical note
Funding:This study is funded by The Dunhill Medical Trust (RPGF1806/66) as part of a series of work building an evidence synthesis suite to inform a future randomised trial of reducing anticholinergic related harm in older adults. The funding sponsors had no role in the design, execution, interpretation or writing of the study.
Open access via Springer agreement.
Data Availability Statement
The online version contains supplementary material available at https://doi.org/10.1007/s11096-021-01293-4.Keywords
- Anticholinergics
- deprescribing
- systematic review
- qualitative research
- intervention implementation
Access to Document
- Stewart_etal_IJCP_Barriers_And_Facilitators_VoR
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.